Related Experiment Video
Updated: Aug 9, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
COVID-19 Vaccination Coverage and Demographic Characteristics of Infants and Children Aged 6 Months-4 Years - United
Insights
COVID-19 vaccination coverage in U.S. children aged 6 months to 4 years remains low, with only 10.1% receiving at least one dose and 5.1% completing the primary series by December 2022. Efforts are needed to increase vaccine uptake in this young population.
Area of Science:
- Pediatric Infectious Diseases
- Public Health Surveillance
- Vaccinology
Background:
- Children under 5 years are susceptible to COVID-19, with over 3 million cases reported by December 2022.
- Hospitalization and intensive care were required for a significant proportion of these children.
- COVID-19 vaccination was authorized for children aged 6 months to 5 years in June 2022.
Purpose of the Study:
- To assess COVID-19 vaccination coverage among children aged 6 months to 4 years in the United States.
- To evaluate the uptake of at least one dose and completion of the primary vaccination series.
- To identify disparities in vaccination coverage by jurisdiction, age group, geographic location, and race/ethnicity.
Main Methods:
- Analysis of vaccine administration data from June 20 to December 31, 2022, for all 50 U.S. states and the District of Columbia.
- Assessment of coverage for at least one dose and completion of a 2- or 3-dose primary vaccination series.
- Stratification of coverage by jurisdiction, age group (6-23 months vs. 2-4 years), county type (urban vs. rural), and race/ethnicity.
Main Results:
- As of December 31, 2022, 10.1% of children aged 6 months to 4 years had received at least one COVID-19 vaccine dose, and 5.1% had completed the primary series.
- Vaccination coverage varied widely by jurisdiction, ranging from 2.1% to 36.1% for at least one dose and 0.7% to 21.4% for series completion.
- Coverage was lower in rural areas (3.4%) compared to urban areas (10.5%), and among non-Hispanic Black (7.0%) and Hispanic (19.9%) children relative to their population proportions.
Conclusions:
- COVID-19 vaccination coverage among young children (6 months-4 years) is substantially lower than in older children.
- Significant disparities in coverage exist across different U.S. jurisdictions, geographic locations, and racial/ethnic groups.
- Targeted strategies are essential to improve COVID-19 vaccine uptake in this vulnerable pediatric population to mitigate severe illness and mortality.
Abstract:
Although severe COVID-19 illness and hospitalization are more common among older adults, children can also be affected (1). More than 3 million cases of COVID-19 had been reported among infants and children aged <5 years (children) as of December 2, 2022 (2). One in four children hospitalized with COVID-19 required intensive care; 21.2% of cases of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) occurred among children aged 1-4 years, and 3.2% of MIS-C cases occurred among infants aged <1 year (1,3). On June 17, 2022, the Food and Drug Administration issued an Emergency Use Authorization (EUA) of the Moderna COVID-19 vaccine for children aged 6 months-5 years and the Pfizer-BioNTech COVID-19 vaccine for children aged 6 months-4 years. To assess COVID-19 vaccination coverage among children aged 6 months-4 years in the United States, coverage with ≥1 dose* and completion of the 2-dose or 3-dose primary vaccination series† were assessed using vaccine administration data for the 50 U.S. states and District of Columbia submitted from June 20 (after COVID-19 vaccine was first authorized for this age group) through December 31, 2022. As of December 31, 2022, ≥1-dose COVID-19 vaccination coverage among children aged 6 months-4 years was 10.1% and was 5.1% for series completion. Coverage with ≥1 dose varied by jurisdiction (range = 2.1% [Mississippi] to 36.1% [District of Columbia]) as did coverage with a completed series (range = 0.7% [Mississippi] to 21.4% [District of Columbia]), respectively. By age group, 9.7 % of children aged 6-23 months and 10.2% of children aged 2-4 years received ≥1 dose; 4.5% of children aged 6-23 months and 5.4% of children aged 2-4 years completed the vaccination series. Among children aged 6 months-4 years, ≥1-dose COVID-19 vaccination coverage was lower in rural counties (3.4%) than in urban counties (10.5%). Among children aged 6 months-4 years who received at least the first dose, only 7.0% were non-Hispanic Black or African American (Black), and 19.9% were Hispanic or Latino (Hispanic), although these demographic groups constitute 13.9% and 25.9% of the population, respectively (4). COVID-19 vaccination coverage among children aged 6 months-4 years is substantially lower than that among older children (5). Efforts are needed to improve vaccination coverage among children aged 6 months-4 years to reduce COVID-19-associated morbidity and mortality.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Socioemotional Development during Infancy
Primary Temperament Types
Bias in Epidemiological Studies
Contingency Table